Related Experiment Video
Updated: Feb 6, 2026

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
Methotrexate intoxication: Beyond the adverse events
Ediz Dalkilic1, Belkıs Nihan Coskun1, Burcu Yağız1
1Division of Rheumatology, Faculty of Medicine, Uludağ University, Bursa, Turkey.
Aim:
Methotrexate (MTX) is the first-line disease-modifying antirheumatic drug in rheumatoid arthritis (RA). However, this anchor may cause some side effects that may range from nausea to mortality. The clinical features of MTX toxicity are under-researched. In this study, we aimed to find out the potential predisposing factors and outcomes of the MTX toxicity (n = 31).
Methods:
The data were collected from 31 patients whose ages ranged from 25 to 81 years, who were suffering from immune-mediated inflammatory diseases and major MTX-related toxicity.
Results:
Out of 31 patients, six (19.4%) used MTX every day, and 13 (41.9%) patients had renal insufficiency who were admitted to the hospital because of mucositis (90.3%) and fever (71%). While using MTX, 27 patients (87.1%) were discharged after the treatment and four patients (12.9%) died.
Conclusions:
Although MTX has high efficacy for the toxicity ratio, wrong use and dosage of MTX may be harmful to patients. Thus, patients should be informed about the proper use of MTX.
Insights
Improper use of methotrexate (MTX) can lead to severe toxicity and death, even though it is an effective treatment for rheumatoid arthritis. Patients must be educated on correct MTX dosage and administration to prevent adverse events.
Area of Science:
- Rheumatology
- Clinical Pharmacology
- Toxicology
Background:
- Methotrexate (MTX) is a primary treatment for rheumatoid arthritis (RA).
- MTX can cause a range of adverse effects, from mild nausea to fatal outcomes.
- Clinical manifestations and risk factors for MTX toxicity require further investigation.
Purpose of the Study:
- To identify predisposing factors for MTX toxicity.
- To characterize the clinical outcomes of MTX toxicity in a patient cohort.
Main Methods:
- Retrospective analysis of 31 patients with immune-mediated inflammatory diseases and significant MTX toxicity.
- Data collection included patient demographics, MTX usage patterns, and clinical outcomes.
Main Results:
- 19.4% of patients used MTX daily; 41.9% had renal insufficiency.
- Common reasons for hospitalization included mucositis (90.3%) and fever (71%).
- While 87.1% of patients were discharged, 12.9% died due to MTX toxicity.
Conclusions:
- Despite MTX's efficacy, incorrect usage and dosage significantly increase toxicity risks.
- Patient education on proper MTX use is crucial for mitigating harm.
- Understanding risk factors like daily dosing and renal insufficiency can improve patient safety.
More Related Videos
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
04:20Author Spotlight: Exploring Microglial Interactions with Stress-Response Circuitry Using the Limited Bedding and Nesting Model
Published on: July 12, 2024
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Integration of Synaptic Events
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Schwarzschild Radius and Event Horizon
The minimum speed required to launch a projectile from the surface of an object to which it is gravitationally bound so that it eventually escapes the object’s gravitational field is called the escape velocity. The escape velocity is independent of the mass of the object. Merging the idea of escape...
Empathy